Applied DNA Sciences, Inc. (BNBX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Applied DNA Sciences, Inc. (BNBX) has a cash flow conversion efficiency ratio of -0.169x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.05 Million) by net assets ($12.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Applied DNA Sciences, Inc. (BNBX) net asset quality to measure how much of total assets are equity-financed.
Applied DNA Sciences, Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Applied DNA Sciences, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Applied DNA Sciences, Inc. to evaluate the quality of earnings relative to operating cash generation.
Applied DNA Sciences, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Applied DNA Sciences, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Im Cannabis Corp
NASDAQ:IMCC
|
-1.169x |
|
Agronomics Ltd
LSE:ANIC
|
-0.005x |
|
RightBridge Ventures Group AB
ST:RIGHTB
|
0.172x |
|
Midsona AB (publ)
ST:MSON-A
|
0.048x |
|
Kollect on Demand Holding Ab
ST:KOLL
|
-0.012x |
|
Premier Miton Group plc
LSE:PMI
|
0.045x |
|
Strikewell Energy Corp
V:SKK
|
0.000x |
|
ProstaLund AB
ST:PLUN
|
-0.052x |
Annual Cash Flow Conversion Efficiency for Applied DNA Sciences, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Applied DNA Sciences, Inc. from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see Applied DNA Sciences, Inc. (BNBX) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $1.94 Million | $-12.52 Million | -6.447x | -321.69% |
| 2024-09-30 | $8.97 Million | $-13.71 Million | -1.529x | -19.81% |
| 2023-09-30 | $4.87 Million | $-6.22 Million | -1.276x | -83.51% |
| 2022-09-30 | $12.91 Million | $-8.98 Million | -0.695x | +42.28% |
| 2021-09-30 | $11.11 Million | $-13.39 Million | -1.205x | -- |
About Applied DNA Sciences, Inc.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic m… Read more